BIM
PLSE icon

BlackRock Investment Management’s Pulse Biosciences PLSE Stock Holding History

BlackRock Investment Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$6K Hold
890
– – ﹤0.01% 3734
2016
Q3 		$6K Hold
890
– – ﹤0.01% 3746
2016
Q2 		$4K Buy
+890
New +$3.83K ﹤0.01% 3892

Other funds holding PLSE

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TF
Trutina Financial Bellevue, Washington $76.7M AUM 19.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BlackRock Investment Management's PLSE Position: Q4 2016 in Review

BlackRock Investment Management held its Pulse Biosciences (PLSE) position steady in Q4 2016 at 890 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #3734.

BlackRock Investment Management first reported a position in PLSE in Q2 2016 and has held it in 3 quarters since. 11 funds tracked by Wall St. Rank hold PLSE as of Q4 2016.

  • BlackRock Investment Management held 890 shares of Pulse Biosciences worth $6K as of Q4 2016.
  • BlackRock Investment Management left its Pulse Biosciences share count unchanged in Q4 2016.
  • Pulse Biosciences made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3734 holding.
  • BlackRock Investment Management first reported a position in Pulse Biosciences in Q2 2016 and has held it in 3 quarters since.
  • 11 funds tracked by Wall St. Rank held Pulse Biosciences as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.